GlassScriptPhysician profile
Savitha Kadakol
NPI 1477569176
$18,883.34
in general payments reported to CMS, 2019-2025
76 companies · $3,204 in 2025
The $3,204 reported for 2025 was more than what 75% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,056 · 2020: $1,437 · 2021: $2,975 · 2022: $3,146 · 2023: $3,007 · 2024: $3,059 · 2025: $3,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,979 · Education: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,979.11 |
| Education | $290.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,352.78 | 2019-2025 | Tagrisso, Calquence, Lynparza |
| Novartis Pharmaceuticals Corporation | $1,290.88 | 2019-2025 | |
| Genentech USA, INC. | $1,104.50 | 2019-2025 | Venclexta, Tecentriq, Perjeta |
| Merck Sharp & Dohme LLC | $1,034.27 | 2019-2025 | Keytruda, Welireg, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $926.80 | 2019-2025 | Opdivo, Opdualag, Eliquis |
| Genzyme Corporation | $881.64 | 2019-2025 | |
| Amgen INC. | $875.02 | 2019-2024 | Kyprolis, Blincyto, Nplate |
| Daiichi Sankyo INC. | $654.95 | 2019-2025 | Enhertu, Vanflyta, Injectafer |
| Eisai INC. | $632.44 | 2019-2025 | |
| Janssen Biotech, INC. | $603.15 | 2019-2025 | Rybrevant, Tecvayli, Darzalex |
| Pfizer INC. | $567.47 | 2019-2025 | |
| Celgene Corporation | $563.55 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Lilly USA, LLC | $560.05 | 2020-2025 | Verzenio, Jaypirca, Retevmo |
| Jazz Pharmaceuticals INC. | $529.23 | 2020-2025 | |
| Incyte Corporation | $505.13 | 2019-2025 | Jakafi, Niktimvo, Monjuvi |
Show all 76 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aveo Pharmaceuticals, INC. | $467.48 | 2021-2025 | Fotivda |
| Abbvie INC. | $454.33 | 2021-2025 | |
| Seagen INC. | $386.20 | 2019-2023 | Padcev, Tukysa |
| Beigene USA, INC. | $289.16 | 2020-2025 | Brukinsa |
| Gilead Sciences, INC. | $283.69 | 2019-2025 | Trodelvy |
| Amag Pharmaceuticals, INC. | $243.45 | 2019-2022 | |
| Astellas Pharma US INC | $220.55 | 2022-2025 | Padcev, Xtandi, Xospata |
| Alexion Pharmaceuticals, INC. | $208.89 | 2019-2023 | Ultomiris |
| Karyopharm Therapeutics INC. | $206.28 | 2022-2025 | Xpovio |
| Sobi, INC | $201.35 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $196.98 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $196.85 | 2021-2025 | Iclusig, Alunbrig, Ninlaro |
| Taiho Oncology, INC. | $196.82 | 2019-2024 | |
| Exelixis INC. | $196.40 | 2019-2024 | Cabometyx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.31 | 2019-2025 | |
| Glaxosmithkline, LLC. | $172.51 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Regeneron Healthcare Solutions, INC. | $165.93 | 2021-2025 | Libtayo |
| Pharmacosmos Therapeutics INC. | $161.55 | 2022-2025 | Monoferric |
| Pharmaessentia USA Corporation | $160.77 | 2022-2025 | Besremi |
| Stemline Therapeutics INC. | $146.13 | 2023-2025 | Orserdu |
| Array Biopharma INC | $142.22 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Dova Pharmaceuticals | $127.06 | 2020-2021 | |
| Agios Pharmaceuticals, INC. | $121.59 | 2020-2025 | Pyrukynd |
| Kite Pharma, INC. | $119.59 | 2020-2024 | Yescarta |
| Azurity Pharmaceuticals, INC. | $105.33 | 2025 | Danziten |
| Emd Serono, INC. | $91.65 | 2019-2025 | |
| Apellis Pharmaceuticals, INC. | $91.14 | 2022-2025 | Empaveli |
| Bayer Healthcare Pharmaceuticals INC. | $82.60 | 2019-2025 | |
| Recordati_rare_diseases_inc. | $73.35 | 2023-2024 | Sylvant |
| Organon LLC | $68.95 | 2021-2025 | |
| Global Blood Therapeutics, INC. | $62.04 | 2021-2022 | |
| Beone Medicines USA, INC. | $58.08 | 2025 | Brukinsa, Tevimbra |
| Puma Biotechnology, INC. | $57.47 | 2019-2025 | |
| Blueprint Medicines Corporation | $57.30 | 2023-2025 | Ayvakit |
| Secura Bio, INC. | $56.21 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $51.59 | 2021-2022 | |
| Servier Pharmaceuticals LLC | $50.49 | 2022-2024 | |
| Bard Peripheral Vascular, INC. | $49.63 | 2025 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon |
| Fortovia Therapeutics, INC. | $48.02 | 2019-2020 | |
| G1 Therapeutics, INC. | $46.18 | 2022-2023 | Cosela |
| Caris Mpi, INC. | $43.62 | 2025 | Mi Cancer Seek |
| Ipsen Biopharmaceuticals, INC | $34.82 | 2023 | Onivyde, Somatuline Depot |
| Geron Corporation | $31.85 | 2025 | Rytelo |
| Hema Biologics, LLC | $30.30 | 2025 | Sevenfact |
| Adaptive Biotechnologies Corporation | $29.80 | 2022 | |
| Macrogenics, INC. | $28.70 | 2021 | |
| Mylan Institutional INC. | $28.25 | 2019-2020 | |
| Octapharma USA, INC. | $25.96 | 2024 | Panzyga |
| Morphosys, US INC. | $25.66 | 2021 | |
| Shield Therapeutics INC | $24.88 | 2025 | |
| Angiodynamics, INC. | $23.93 | 2021 | |
| Neuros Medical, INC. | $21.26 | 2025 | Altius |
| Deciphera Pharmaceuticals INC. | $19.29 | 2021 | |
| Coherus Oncology, INC. | $18.69 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $18.53 | 2019 | |
| Endologix LLC | $18.40 | 2021 | |
| Mirati Therapeutics, INC. | $18.24 | 2024 | Krazati |
| Tesaro, INC. | $15.95 | 2019 | |
| Novocure INC. | $15.16 | 2025 | Optune Lua (Novottf-200t) |
| Sandoz INC. | $14.78 | 2024 | Cyclophosphamide |
| Alnylam Pharmaceuticals INC. | $13.29 | 2020 |
Drugs and devices associated with these payments
Keytruda $551Venclexta $464Fotivda $383Sarclisa $372Zepzelca $309Reblozyl $282Enhertu $276Lenvima $267Jakafi $253Verzenio $222Padcev $215Opdivo $184Tagrisso $181Calquence $170Brukinsa $163Scemblix $159Rybrevant $153Xpovio $149Doptelet $148Orserdu $146Lynparza $144Besremi $144Monoferric $142Ibrance $137Kisqali $135Tukysa $126Iclusig $123Tecentriq $121Cabometyx $120Vanflyta $116Braftovi $114Perjeta $114Phesgo $114Jaypirca $112Tecvayli $108Darzalex $108Danziten $105Alecensa $96.98Welireg $89.60Pyrukynd $85.07Trodelvy $84.35Tasigna $80.12Cablivi $77.79Enjaymo $77.79Ayvakit $77.34Mektovi $77.17Lorbrena $76.02Retevmo $74.18Sylvant $73.35Inqovi $71.81Lonsurf $71.81Jemperli $69.82Opdualag $69.26Kyprolis $67.38Empaveli $65.81Talvey $64.41Rozlytrek $63.87Imbruvica $62.80Blincyto $59.90Polivy $59.66Xgeva $56.58Nplate $56.58Kadcyla $53.88Libtayo $53.25Lumakras $52.61Wayrilz $48.22Zejula $46.13Erleada $44.80Vectibix $43.77Mi Cancer Seek $43.62Synthroid $42.19Yescarta $41.77Imfinzi $41.59Keytruda Qlex $38.71Ojjaara $38.57Injectafer $37.32Somatuline Depot $34.82Onivyde $34.82Pomalyst $34.04Tibsovo $33.87Rytelo $31.85Oxbryta $31.03Sevenfact $30.30Carvykti $29.69Piqray $27.12Niktimvo $26.13Panzyga $25.96Rotarexs 6 F X 135 Cm $25.16Accrufer $24.88Datroway $24.61Lutonix Drug Coated Balloon $24.47Synagis $24.30Altius $21.26Alunbrig $21.09Shingrix $20.97Vitrakvi $20.66Stivarga $20.66Nubeqa $20.66Pluvicto $20.53Balversa $20.38
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Savitha Kadakol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.